Challenges and opportunities of combining RWE and RCT data - a podcast by Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry

I've been working on RWE most of my career and the clinical trial data for a while now. And 20 years ago, we would have never thought about merging them together but there's a lot of opportunities if we do this.

The recent advances in analytical methods for combining evidence from RCTs and non-RCTs, and the development of new frameworks for the inclusion of RWE in HTA have provided a greater insight on how issues around RWE uncertainty can be dealt with when estimating treatment effects for new technologies.

Further episodes of The Effective Statistician - in association with PSI

Further podcasts by Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry

Website of Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry